Adverum Biotechnologies, Inc.
USD4.36
+0.00 (+0.00%)
CEO
Laurent Fischer
IPO Date
2014-07-31
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$4.24
Prev. Close
$4.36
Day Low
$4.24
Day High
$4.36
52W Low
$1.78
52W High
$6.07
Market Cap
$0.10B
Volume
0.68M
| -3.6 |
| 31 Dec 2022 | FY | 0.0% | 0.0% | -85.1% | -50.1% | 0.59 | 5.91 | -2.2 |
| 31 Dec 2021 | FY | 100.0% | -1940.5% | -46.0% | -33.1% | 0.33 | 14.88 | -11.9 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | -27.1% | -24.4% | 0.07 | 20.82 | -86.0 |
| 31 Dec 2019 | FY | 0.0% | -25794.4% | -36.9% | -29.0% | 0.19 | 9.06 | -131.8 |
| 31 Dec 2018 | FY | 0.0% | -4505.4% | -36.1% | -34.0% | 0.00 | 19.48 | -26.6 |
| 31 Dec 2017 | FY | 0.0% | -3036.6% | -30.5% | -27.8% | 0.00 | 18.15 | -27.2 |
| 31 Dec 2016 | FY | 0.0% | -7817.7% | -52.8% | -48.5% | 0.00 | 22.76 | -9.2 |
| 31 Dec 2015 | FY | 100.0% | -2046.3% | -18.8% | -18.0% | 0.00 | 39.70 | -51.1 |
| -0.2 |
| 31 Mar 2025 | Q1 | 0.0% | 0.0% | -178.0% | -34.2% | 3.53 | 3.57 | -0.5 |
| 31 Dec 2024 | Q4 | 0.0% | 0.0% | -85.6% | -33.7% | 1.30 | 5.73 | -0.4 |
| 30 Sept 2024 | Q3 | 100.0% | -2713.4% | -18.8% | -11.6% | 0.51 | 5.82 | -1.4 |
| 30 Jun 2024 | Q2 | 0.0% | 0.0% | -18.2% | -12.0% | 0.44 | 7.99 | -1.2 |
| 31 Mar 2024 | Q1 | 0.0% | 0.0% | -14.9% | -10.1% | 0.41 | 9.24 | -2.1 |
| 31 Dec 2023 | Q4 | 0.0% | 0.0% | -35.3% | -15.2% | 1.10 | 5.14 | -4.6 |
| 30 Sept 2023 | Q3 | 0.0% | 0.0% | -32.0% | -16.7% | 0.74 | 4.32 | -6.6 |
| 30 Jun 2023 | Q2 | 0.0% | 0.0% | -24.0% | -13.1% | 0.69 | 3.31 | -7.3 |